By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Cancer Institute is seeking clinically annotated biospecimens for a number of cancer types that it will use in The Cancer Genome Atlas (TCGA) program, a collaboration with the National Human Genome Research Institute which aims to study at least 20 cancers over the next five years.

NCI expects that it will need more than 40,000 biosamples to supply TCGA over the coming years to study all of these cancer varieties.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.